Expansion Opportunity Series C funding totaling 30M and participation from notable investors signals strong growth potential and willingness to scale operations; target healthcare partners and payers in new markets where InStride Health can expand pediatric anxiety and OCD care programs.

Payer Alignment As an insurance-based specialty provider with a focused pediatric mental health model, there is a clear sales opening with health plans and employer-sponsored coverage looking to enhance access to CBT and exposure therapy for youth, potentially reducing long-term treatment costs.

Awarded credibility Mental Health Innovation Award and MedTech Breakthrough recognition bolster market credibility; leverage awards in outreach to payers, health systems, and strategic partners to open conversations around contract opportunities and pilot programs.

Tech-enabled Care Existing tech stack and data tools (Looker, Power BI, PostgreSQL, GitHub, Marketo) suggest capacity for data-driven outcomes reporting; propose partnerships that require outcome tracking, quality metrics, and value-based care analytics.

Market Readiness Recent press underscores plans to expand into new markets; align with regional health systems and children’s hospitals seeking specialized pediatric anxiety/OCD services, offering scalable care delivery models and turnkey program implementations.